GlassScriptPhysician profile
David Sean Willcutts
NPI 1992232508
$5,137.80
in general payments reported to CMS, 2019-2025
7 companies · $4,496 in 2025
The $4,496 reported for 2025 was more than what 90% of Pediatric Gastroenterology providers received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $112 · 2021: $242 · 2022: $232 · 2023: $55.42 · 2025: $4,496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,600 · Travel and Lodging: $1,618 · Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,600.00 |
| Travel and Lodging | $1,617.76 |
| Food and Beverage | $333.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mirum Pharmaceuticals, INC. | $4,495.70 | 2025 | Livmarli |
| Abbvie INC. | $382.96 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $145.90 | 2020-2023 | Gattex |
| Qol Medical, LLC | $56.97 | 2020 | |
| Amgen INC. | $22.00 | 2022 | |
| Travere Therapeutics, INC. | $19.53 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $14.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Willcutts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.